Tim Lugo's Stock Ratings

William Blair Analyst

Tim Lugo is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024

Overall Average Return

-12.1%

Smart Score

38.5%

Overall Average Return Percentile

17th

Number of Ratings

16
Buy NowGet Alert
07/31/2024APLTBuy Now
Applied Therapeutics
$5.80Initiates → OutperformGet Alert
04/15/2024LENZBuy Now
LENZ Therapeutics
$24.95Initiates → OutperformGet Alert
03/28/2024SLDBBuy Now
Solid Biosciences
$9.17336.21% → $40Initiates → OutperformGet Alert
03/12/2024ZVRABuy Now
Zevra Therapeutics
$5.95Initiates → OutperformGet Alert
01/29/2024ABBVBuy Now
AbbVie
$186.90UpgradeMarket Perform → OutperformGet Alert
12/18/2023ALLKBuy Now
Allakos
$0.94UpgradeMarket Perform → OutperformGet Alert
11/13/2023ACRSBuy Now
Aclaris Therapeutics
$1.34DowngradeOutperform → Market PerformGet Alert
11/01/2023EYENBuy Now
Eyenovia
$1.40Initiates → OutperformGet Alert
09/21/2023TVTXBuy Now
Travere Therapeutics
$9.50DowngradeOutperform → Market PerformGet Alert
09/20/2023SPRYBuy Now
ARS Pharmaceuticals
$10.97DowngradeOutperform → Market PerformGet Alert
07/25/2023ABBVBuy Now
AbbVie
$186.90Initiates → Market PerformGet Alert
01/04/2023SPRYBuy Now
ARS Pharmaceuticals
$10.97Initiates → OutperformGet Alert
07/22/2022VTGNBuy Now
VistaGen Therapeutics
$3.46DowngradeOutperform → Market PerformGet Alert
03/08/2022BBIBuy Now
Brickell Biotech
Initiates → OutperformGet Alert
12/22/2021ALLKBuy Now
Allakos
$0.94DowngradeOutperform → Market PerformGet Alert
11/22/2021BMRNBuy Now
Biomarin Pharmaceutical
$85.23UpgradeMarket Perform → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free